PREVENT
Posted November 4, 2022
The prostate gland is a small, walnut-shaped structure between the bladder and the penis. Almost 200,000 men are diagnosed with prostate cancer each year. It most often impacts men over age 60. It is the second-leading cause of cancer death in men after lung cancer. The good news is that prostate cancer can often be successfully monitored and treated when it is detected early. That’s why it’s important to talk to your primary care provider about the risks and benefits of prostate cancer screening.
By age 50, about half of all men have small changes in the size and shape of the cells in their prostate. This is called prostatic intraepithelial neoplasia (PIN), which can be a precursor to cancer. If PIN is present, the best strategy is to have a biopsy to check for cancer. If PIN is the only finding, then yearly follow-up screening with a prostate-specific antigen (PSA) blood test and digital rectal examination (DRE) is recommended.
If your PSA result is above the expected range, your provider will talk to you about what the reading means. This conversation will include information on your risks, and monitoring and cancer treatment options so you can make an informed decision about your health.
Treatment for prostate cancer depends on your age and general health, the stage and grade of the cancer, whether or not it has spread, and side effects of treatment.
Ask your primary care provider how to lower your risk of prostate cancer. These may recommend lifestyle changes, such as a diet lower in animal fats and high in fruits and vegetables and more exercise. There are no medicines or supplements approved by the FDA for preventing prostate cancer.
The best advice to catch prostate cancer early is to see a primary care provider yearly with a prostate cancer screen starting at age 50 if you're at average risk. Consider screening earlier if you’re at high risk.
Prostate and testicular cancer care
Get screened yearlyFind a provider
Search nowGet fun, inspiring, provider-reviewed articles sent to your inbox.
Sign up for our email newsletter